Publicaciones (92) Publicaciones de ANTONIO RAFAEL CÁLIZ CÁLIZ

2024

  1. Exploración del aparato locomotor

    Historia clínica y exploración física en medicina (Avicam), pp. 79-86

2023

  1. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study

    RMD open, Vol. 9, Núm. 1

  2. High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function

    Rheumatology International, Vol. 43, Núm. 2, pp. 253-263

  3. Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis

    Reumatologia Clinica, Vol. 19, Núm. 10, pp. 533-548

  4. Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry

    Reumatologia Clinica, Vol. 19, Núm. 9, pp. 500-506

2022

  1. Correction to: Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry (Rheumatology and Therapy, (2022), 9, 4, (1031-1047), 10.1007/s40744-022-00446-9)

    Rheumatology and Therapy

  2. Fisiopatología del sistema articular y el hueso

    Bases de la medicina interna. Fisiopatología y propedéutica médica: Volumen II (Avicam), pp. 251-270

  3. Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry

    Rheumatology and Therapy, Vol. 9, Núm. 4, pp. 1031-1047

  4. Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis

    Reumatologia Clinica, Vol. 17, Núm. 9, pp. 536-542

  2. Genetic polymorphisms of ggh and abcc2 are associated with methotrexate intolerance in patients with rheumatoid arthritis

    Journal of Clinical Medicine, Vol. 10, Núm. 18

  3. OBSTETRIC OUTCOMES IN PREGNANT WOMEN DIAGNOSED OF ANTIPHOSPHOLIPID SYNDROME

    Revista Medica Clinica Las Condes, Vol. 32, Núm. 1, pp. 128-135

  4. Psychopathology as a moderator of the relationship between physical symptoms and impairment in fibromyalgia patients

    Psicothema, Vol. 33, Núm. 2, pp. 214-221

  5. Symmetry criterion for patients with rheumatoid arthritis of the foot: A cross-sectional study

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 7

  6. Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment

    Frontiers in Pharmacology, Vol. 12

  7. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts

    Frontiers in Immunology, Vol. 12

2020

  1. Clinical Manifestations of Trauma Exposure in Fibromyalgia: The Role of Anxiety in the Association Between Posttraumatic Stress Symptoms and Fibromyalgia Status

    Journal of Traumatic Stress, Vol. 33, Núm. 6, pp. 1082-1092

  2. Combined cognitive-behavioral therapy for fibromyalgia: Effects on polysomnographic parameters and perceived sleep quality

    International journal of clinical and health psychology, Vol. 20, Núm. 3, pp. 232-242

  3. Foot health and quality of life in patients with rheumatoid arthritis: A cross-sectional study

    BMJ Open, Vol. 10, Núm. 5

  4. Impact of single-nucleotide polymorphisms of CTLA-4, CD80 and CD86 on the effectiveness of abatacept in patients with rheumatoid arthritis

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-17